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Abstract
Nonsense-mediated RNA decay (NMD) is a highly conserved and selective RNA degradation 
pathway that acts on RNAs terminating their reading frames in specific contexts. NMD is 
regulated in a tissue-specific and developmentally controlled manner, raising the possibility that it 
influences developmental events. Indeed, loss or depletion of NMD factors have been shown to 
disrupt developmental events in organisms spanning the phylogenetic scale. In humans, mutations 
in the NMD factor gene, UPF3B, cause intellectual disability (ID) and are strongly associated with 
autism spectrum (ASD), attention deficit hyperactivity disorder (ADHD), and schizophrenia 
(SCZ). Here, we report the generation and characterization of mice harboring a null Upf3b allele. 
These Upf3b-null mice exhibit deficits in fear-conditioned learning, but not spatial learning. 
Upf3b-null mice also have a profound defect in prepulse inhibition (PPI), a measure of 
sensorimotor gating commonly deficient in individuals with SCZ and other brain disorders. 
Consistent with both their PPI and learning defects, cortical pyramidal neurons from Upf3b-null 
mice display deficient dendritic spine maturation in vivo. In addition, neural stem cells from 
Upf3b-null mice have impaired ability to undergo differentiation and require prolonged culture to 
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give rise to functional neurons with electrical activity. RNA sequencing (RNAseq) analysis of the 
frontal cortex identified UPF3B-regulated RNAs, including direct NMD target transcripts 
encoding proteins with known functions in neural differentiation, maturation, and disease. We 
suggest Upf3b-null mice serve as a novel model system to decipher cellular and molecular defects 
underlying ID and neuro-developmental disorders.
INTRODUCTION
NMD is a RNA degradation pathway initially thought to serve only as a quality control 
mechanism to degrade aberrant mRNAs encoding potentially deleterious truncated proteins1. 
More recently, NMD has been shown to degrade subsets of normal mRNAs in species 
spanning the phylogenetic scale2–7. Thus, NMD is not only a quality control pathway, but 
also acts to shape the normal transcriptome. This has led to the hypothesis that NMD 
regulates normal events, including normal development, which has been supported by many 
recent studies3,8–11.
NMD is triggered by in-frame nonsense codons in specific contexts. The best-characterized 
context that elicits NMD is an exon-exon junction (intron) greater than ~55 nucleotides (nt) 
downstream of the stop codon defining the end of the main ORF12. This “−55 nt boundary 
rule” is governed by a set of proteins called the exon-junction complex (EJC) that is 
recruited just upstream of exon-exon junctions after RNA splicing13. Evidence suggests that 
EJCs within the main ORF are displaced by translocating ribosomes, but any that remain 
downstream of the main ORF can interact with factors recruited upon translation 
termination, leading to activation of the NMD pathway13. It is thought that stop codons less 
than ~55 nt downstream of the last exon-exon junction fail to trigger NMD because they 
terminate translation after translating ribosomes displace the most 3′ EJC (given the known 
length of the EJC and ribosome footpads). Another NMD-inducing feature is a long 3′ 
UTR, which may elicit NMD by favoring formation of RNA decay complexes over 
translation complexes7,14. Finally, it has been shown that upstream open reading frame 
(uORFs) trigger NMD under some circumstances, perhaps by virtue of the ability of the stop 
codon in the uORF to trigger premature translation termination and thereby recruit mRNA 
decay enzymes15,16. To date, the exact mechanisms by which NMD factors are orchestrated 
to detect these features is unknown.
Several lines of evidence suggest that NMD is not a linear pathway, but rather has different 
branches. This was first suggested by NMD factor knockdown experiments in HeLa cells. 
Depletion of EJC factors and the NMD factor, UPF2, selectively upregulated only some 
NMD substrate RNAs, providing evidence for EJC- and UPF2-independent branches of 
NMD17,18. The existence of a UPF2-independent branch of NMD was later confirmed in 
Upf2-KO mice19. The existence of a UPF3B-independent branch of the NMD pathway was 
initially suggested by two lines of evidence. First, lymphoblastoid cells from patients 
harboring UPF3B frameshifts mutations (that generate premature termination codons) have 
reduced levels of UFP3B mRNA (indicative of active NMD) despite no active UPF3B 
protein20. Second, either stable or transient depletion of UPF3B from HeLa cells failed to 
reverse the destabilization of a subset of NMD substrates16. The existence of both UPF3B-
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dependent and –independent branches of NMD was later confirmed in vivo21,22. NMD 
branches afford the opportunity for more subtle regulation than regulation conferred by the 
NMD pathway as a whole. For example, by degrading only a subset of NMD target 
transcripts, a given NMD branch can influence a given development event in a more specific 
manner.
Recent genetic studies have revealed that mutations in the UPF3B gene cause intellectual 
disability (ID) in humans20,23–26. Mutations in UPF3B are also associated with other 
neurodevelopmental disorders, including autism spectrum disorder (ASD), schizophrenia 
(SCZ) and attention deficit hyperactivity disorder (ADHD)23,25,27. These findings raise the 
possibility that NMD is important for brain development, a notion supported by recent 
studies. First, neural differentiation cues trigger NMD downregulation, an event that is 
sufficient to trigger neuronal differentiation28. Second, NMD downregulation is triggered, at 
least in part, by brain-enriched miRNAs that target the NMD factors UPF1, CASC3, and 
UPF3B28,29. Third, UPF3B is expressed in neural progenitor cells (NPCs) in subventricular 
zone of developing cortex and its knockdown increases NPC proliferation and reduces their 
differentiation3. These in vitro studies support the attractive possibility that NMD and 
UPF3B functions in neural development but it remains to be determined whether this is the 
case in vivo.
To elucidate the role of UPF3B in vivo, we generated Upf3b-null mice. We found that these 
mutant mice have selective defects in behavior that, in part, mimic those found in human 
UPF3B patients. These defects include specific memory and sensorimotor gating deficits 
accompanied by dendritic spine maturation defects. Cultured mouse neural stem cell 
(mNSCs) from Upf3b-null mice exhibit proliferation and differentiation abnormalities that 
suggest Upf3b functions by promoting neural differentiation. To investigate the underlying 
mechanism, we performed RNA sequencing (RNA-seq) analysis on Upf3b-null vs. control 
frontal cerebral cortices and identified a remarkably selective set of RNAs dysregulated by 
loss of Upf3b, several of which we found are high-confidence direct NMD targets. Several 
of these mRNAs encode neural differentiation factors and proteins known to be associated 
with neuro-developmental disorders. Together, our results suggest Upf3b-null mice will be 
critical for elucidating how abnormalities in post-transcriptional events lead to specific 
learning and sensorimotor gating defects.
MATERIALS AND METHODS
Cell culture
Gene-trap C57BL6 embryonic stem cell (ESC) clones harboring insertions in the Upf3b 
gene (obtained from the Texas A&M Institute for Genomic Medicine) were cultured as 
described in our previous study21. The IST14619B5 gene trap clone was injected into 6(Cg)-
Tyrc-2J/J (albino) donor blastocysts to generate chimeric Upf3b-mutant mice, which were 
bred with C57BL/6J mice to obtain progeny harboring a germline copy of the mutant Upf3b 
(IST14619B5 gene trap) allele. mNSC cultures were maintained and differentiated as 
described28. In brief, mNSCs cultures were isolated from E14.5 Upf3b-null and control 
embryos (n=3 per genotype) and cultured as neurospheres in the presence of EGF and FGF 
(StemCell Technologies) for 2 weeks before being cryopreserved. Cryopreserved cells were 
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then thawed and expanded for an additional 3 weeks before experimentation. For 
multipotent differentiation experiments, neurospheres were expanded in the presence of EGF 
and FGF to maintain multipotency. Neurosphere cultures (n=3 per genotype) were 
dissociated into single cells and plated onto ploy-L-ornithine and laminin-coated coverslips 
(Becton Dickinson and Company). Cells were grown in the presence of EGF for 24 hours 
before EGF was removed to promote differentiation. Cultures were fixed for analysis 72 
hours after plating. Fixed cultures were stained for IF analysis, using standard techniques, 
employing the following primary antibodies as per manufactures instructions: anti-SOX2 
(Millipore, AB5603) anti-GFAP (Sigma, G9269) anti-βIII-TUBULIN (Sigma, T5076). A 
minimum of 300 cells were scored per culture (n=3 per genotype; SOX2 staining: n=902 
control cells, n=990 Upf3b-null cells; GFAP/TUBB3 staining: n=904 control cells, n=956 
Upf3b-null cells). For the EdU pulse-chase experiment, mNSCs were incubated for 48 hours 
after plating and then labeled with 10 μM EdU (Life Technologies) for 8 hours before being 
removed and cultured for an additional 24 hours and fixed. EdU was detected using the 
Clickit-Edu kit (Life Technologies) and immunofluorescently stained using both SOX2 and 
ant-KI67 (Abcam, ab15580) antibodies. At least 100 EdU-positive cells were scored per 
culture (n=3 per genotype; SOX2 staining, n=305 control cells, n= =308 Upf3b-null cells; 
KI67 staining, n=306 control cells, n=304 Upf3b-null cells). All analyses were conducted 
blind to genotype. All graphed data points for cell counts represent the mean of n=3 of each 
genotype (biological replicates) and error bars represent standard deviation. Significance 
was set at p<0.05 using Students two-tailed t-test assuming equal variance. Total cellular 
RNA was isolated from mNSCs and other cell cultures using Trizol (Thermo Fisher 
Scientific), as described29. For the electrophysiology experiments, directed differentiation of 
NSC cultures (n=3 per genotype) into pure populations of neurons was conducted as 
previously described30. In brief, neurospheres were dissociated into single cells and plated 
on multi-electrode array culture plates featuring 64 planar indium tin-oxide (ITO) platinum 
black electrodes (50 μm × 50 μm electrode size in 8 X 8 rows, with 150 μm spacing). 
Culture were grown in FGF in the absence of EGF for 1 week to promote expansion of 
neural-committed mNSCs (over glial-committed mNSCs) before FGF removal to drive 
neuronal differentiation and maturation. Spontaneous neuron spikes were measured with the 
integrated MED64 system (Alpha MED Science, Japan).
Mice
Adult C57BL/6 (8- to 11-weeks old) Upf3b-null and littermate control mice used for our 
study. These mice were maintained in agreement with protocols approved by the 
Institutional Animal Care and Use Committee at the University of California, San Diego. All 
animals were housed under a 12h light/12h dark cycle and provided with food and water ad 
libitum. Animal procedures comply with the UC San Diego IACUC and ACP standards. 
Power analyses for behavioral tests were performed on data generated in the Mouse 
Behavioral Assessment Core examining genotype effects. A simple calculator (http://
powerandsamplesize.com/Calculators/) that uses effect size, n, and p = 0.05 significance 
level was used. Y-maze alteration: N = 14, power = 0.96; Barnes maze test: N = 12, power = 
0.72; acoustic startle, PPI: N = 8, power = 0.92; cued and contextual fear conditioning: N = 
10, power = 0.97; EEG studies (sleep, auditory brainstem response): N = 6, power = 0.82. 
Sample sizes were estimated based on power analyses of past similarly designed studies. 
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None of the samples or animals was excluded from analyses. All animals were treated 
identically. Male mice were always tested prior to females; mice within a cage were 
randomly assigned numbers so that the different genotypes were randomly ordered. The 
experimenters were blinded to genotype throughout testing and initial analyses and were 
only unblinded at the time of graphing and statistical analysis. All mice were assigned a 
discreet number that was used to track them throughout experimentation and this number 
was not associated with a genotype until unblinding. The behavioral data were normally 
distributed and variances were similar between groups to be compared, therefore parametric 
statistical tests were justified and used.
Protein analysis
For Western blot analysis, adult female wild-type and Upf3b−/− brains were isolated, 
chopped into small pieces, and placed into a RIPA lysis buffer (Sigma) containing 
phenylmethane sulfonyl fluoride for 30 minutes on ice to lyse cells and release proteins. 
Protein concentration was calculated using a DC BSA assay (Bio-Rad Laboratories) and 
Western blotting was performed as described previously28. For immunohistochemistry, adult 
male wild-type and Upf3b-null brains were isolated and immediately placed into optimal-
cutting temperature (OCT [Sakura]) solution and frozen for cryosectioning. Cryosectioning 
was done at 12 μm thickness using a Leica 1500 machine and tissue sections were placed on 
Superfrost microscope slides (Fisherbrand) and stored at −80C until ready for use. At the 
time of staining, the sections were air-dried for 20 min, followed by incubation with 4% 
paraformaldehyde (Electron Microscopy Sciences) for 10 min to fix the tissue. After PBS 
washes, the sections were permeabilized with 0.1% Triton-X 100 for 10 min. The 
subsequent staining procedures were done as previously described29. mNSCs 
immunohistochemistry was performed as described previously31. Microscopy analysis was 
performed using a Leica AF6000 epi-fluorescence microscope.
Behavioral analyses
In all assays, Upf3b-mutant and wild-type littermates were compared. Prepulse inhibition 
(PPI) testing was performed as described in a previous study, using startle chambers to 
produce high-frequency acoustic stimuli32. Locomotor, light/dark transfer, cued and 
contextual fear conditioning, and Barnes maze test were performed as previously 
described33. Y maze and paw clasping behavior were performed as described previously34.
Golgi staining of neurons and dendritic spine analysis
Golgi staining was performed using the FD Rapid GolgiStain Kit (FD Neurotechologies). In 
brief, freshly dissected brains were immersed in the impregnation solution for 3 weeks in the 
dark and cryopreserved. Sections were cut to 0.1 mm thickness and placed on gelatin-coated 
microscope slides and stained according to the manufacturer’s protocol. Imaging of 
dendritic spines was performed using the BioRad Radiance 2000 laser scanning, brightfield 
upright confocal microscope. Dendritic spine counting was done using ImageJ and Cell 
Counter plug-in script.
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RNAseq analyses
RNA was isolated from five Upf3b-null frontal cortices and six wild-type mouse frontal 
cortices with the Direct-zol RNA MiniPrep Plus Kit (Cat. R2072; ZYMO Research), quality 
evaluated by TapeStation (Agilent), and sequenced with an Illumina HiSeq 4000 High-
Throughput Sequencing System. Libraries were constructed and reads mapped with the 
RNA-seq aligner STAR35,36. Counts for each gene were quantified using the python script 
rpkmforgenes.py37 and annotated using the Refseq mm10 genome. Reads were filtered, such 
that genes without at least one sample with at least 10 raw reads and one RPKM reads were 
removed from the analysis. Overlapping RefSeq transcripts were collapsed giving one 
expression value per gene locus. The count data was normalized and differential expression 
was performed using the R (v.3.1.1) package DESeq2 (v.1.4.5). In brief, DESeq2 uses 
negative binomial generalized linear models and shrinkage estimation for dispersions and 
fold changes to improve stability and interpretability of the estimates. It reports a P value 
and an adjusted P value using the Benjamini–Hochberg procedure. Genes with an adjusted P 
value <0.05 were considered differentially expressed unless otherwise noted. Other plots 
were constructed using the R(v.3.1.1) package gplots. All functional enrichment analyses 
were generated using DAVID gene annotation and analysis resource38,39. For analysis of 
NMD-inducing features, corresponding Refseq transcripts were converted into Ensemble 
transcript IDs and sequences were obtained using the UCSC Table Browser. To identify 
NMD-inducing features, we used a script developed by the laboratory that was previously 
published40. Transcripts defined as having NMD-inducing features have either a ≥1200 nt 
3′UTR, a stop codon defining the main ORF >55 nt upstream of at least one exon-exon 
junction, or an uORF at least 30 codons long defined by an ATG in a Kozak context. Only 
Ensembl-defined transcripts harboring both 5′UTR and 3′UTR regions were considered for 
analysis.
RESULTS
Generation of Upf3b-null mice
To generate Upf3b-mutant mice, we first screened two ESC clones harboring gene trap 
insertions for Upf3b expression. One ESC clone had the cassette insertion in intron 1 
(IST14619B5) and the other in intron 4 (IST10135A8) (Supplementary Figure S1a). In both 
clones, use of the splice accepter (SA) sequence in the cassette leads to the generation of a 
fusion transcript predicted to encode a truncated form of UPF3B protein. We analyzed the 
expression level of these two ESC clones and found that clone IST14619B5 had >90% 
reduced level of Upf3b mRNA relative to that in control ESCs, whereas clone IST10135A8 
exhibited only a ~50% reduction in Upf3b mRNA levels (Supplementary Figure S1b). Of 
note, the reduction in Upf3b mRNA level is likely to be an underestimate, as there were 
probably some feeder fibroblasts (which express wild-type Upf3b) still remaining, even 
though we passaged the ESCs 3 times in the absence of fresh feeder cells.
We selected the IST14619B5 clone to inject into donor blastocysts for the generation of 
chimeric Upf3b-mutant mice. Following breeding for germline transmission of the mutant 
Upf3b gene, we obtained global Upf3b-mutant mice, which were normal in appearance and 
were viable and fertile. Upf3b mRNA levels were decreased by >100-fold in most tissues, 
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and NMD substrates were upregulated, as reported previously21. To determine whether 
protein expression of UPF3B is also extinguished in these mice, we performed Western blot 
analysis and found that UPF3B protein was undetectable in brains from Upf3b-mutant mice, 
whereas it was abundant in control brains (Supplementary Figure S1c). Immunofluorescence 
analysis also showed absence of UPF3B in the brain, including the hippocampus and 
cerebral cortex (Supplementary Figures S2a & S2b). We conclude that the mutant mice we 
generated lack detectable UPF3B and thus we will refer to them as Upf3b-null mice.
Behavioral analysis of Upf3b-null mice
Given that humans with UPF3B mutations invariably exhibit intellectual disability and also 
often suffer from neuro-developmental disorders (see Introduction), we performed 
behavioral tests on male and female Upf3b-null mice. For females, we compared complete 
KO (Upf3b−/−) and heterozygotes (Upf3b+/−) with littermate controls (Upf3b+/+). For males, 
we compared only KO (Upf3b−/Y) with littermate controls (Upf3b+/Y), as Upf3b is a X-
linked gene. We performed our initial analysis on both sexes together and thus analyzed only 
Upf3b-null and wild-type mice. Later, we analyzed the 3 genotypes separately in females to 
determine whether there was an effect of heterozygosity.
A general health, sensory, and neurological screen revealed that Upf3b-null mice were not 
significantly different from controls in most respects. For example, Upf3b-null mice did not 
have a significant vision deficit, as determined using the optomotor test (Supplementary 
Figure S3a). Upf3b-null mice also performed normally in the light/dark transfer test of 
anxiety-like behavior41 and in a locomotor activity test in which ambulatory, center, and 
rearing activity is recorded (Supplementary Figures S3b & S3c). The only motor defect we 
observed in Upf3b-null mice was paw-clasping behavior (Supplementary Figure S3d), a trait 
relatively common in mouse models of several neurological disorders, including 
Alzheimer’s disease, Rett’s syndrome, and Huntington’s disease42. In this test, mice are 
picked up by the distal third of their tails and observed for 10 sec to determine if they clasp 
their front paws.
Upf3b-null mice have cued and contextual fear learning defects
Given the paw-clasping trait observed in Upf3b-null mice and the fact that UPF3B mutations 
in humans cause ID (see Introduction), we next assessed whether Upf3b-null mice have 
learning defects. We observed no significant effects of genotype (or sex x genotype 
interactions) in either the Y maze test (Supplementary Figures S4a & S4b) or the Barnes 
maze test (Supplementary Figures S4c & S4d), which measure simple working memory and 
spatial learning/memory, respectively. In striking contrast, Upf3b-null mice had deficits in 
both contextual and cued fear conditioning (Figures 1a & 1b). Examination of the context 
test using repeated measures analysis of variance (RMANOVA; habituation vs. context 
exposure) in male and female Upf3b-null and control mice revealed significant genotype 
effects (F [1,47] = 5.5; p <0.05) and genotype x test effects (F [1,47] = 6.7; p <0.05), with no 
difference between sexes. Upf3b-null mice also showed decreased freezing in the context 
test relative to wild-type mice (F [1,47] = 6.1; p <0.05). Examination of the cued test (pre-
cue exposure vs. cue exposure) also revealed significant genotype effects (F [1,47] = 19.5, p 
<0.0001) and genotype x test effects (F [1,47] = 19.0, p <0.0001). Upf3b-null mice showed 
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decreased freezing in the cued test relative to wild-type mice (F [1,47] = 19.9, p <0.0001). In 
females, there was a significant effect of genotype x test in the cued test (RMANOVA pre-
cues vs. cue exposure; (F [2,34] = 5.0, p <0.05) with the Fisher’s PLSD post-hoc testing 
revealing a difference between Upf3b-null and control mice during cue exposure. 
Heterozygotes exhibited an intermediate response. Together, these data suggest UPF3B is 
specifically critical for both contextual and cued fear-based learning, but not for simple 
working memory or spatial learning and memory.
Sleep alterations in Upf3b-null mice
We observed that Upf3b-null mice also exhibited abnormal sleep behaviors. RMANOVA 
analysis of male and female Upf3b-null and control mice revealed significant overall 
genotype differences in time spent awake (KO>WT; F [1,25] = 8.3; p <0.01), in slow wave 
sleep (WT>KO; F [1,25] = 5.7; p <0.05), and in rapid eye movement (REM) sleep 
(WT>KO; F [1,25] = 14.6; p <0.001) (Figure 1c). Deeper analyses showed that Upf3b-null 
mice had more episodes of these vigilance states than control mice, but that the average 
episode durations were shorter (data not shown). When females were analyzed separately 
this genotype effect did not reach significance (Figure 1d). This was likely due to a slight 
increase in variance with fewer mice included and not due to a sex difference as there were 
no overall sex differences in vigilance states. There were significant sex x light phase 
interactions in all vigilance states, but no interactions of genotype x sex or 3-way 
interactions (Figure 1d and data not shown).
Upf3b-null mice exhibit startle reflex and PPI deficits
The startle response is a largely automatic defensive response to sudden stimuli. Given that 
the startle response is deficient in several mouse models of human neural diseases43, we 
examined Upf3b-null mice for this behavior. We found that Upf3b-null males and females 
exhibited a statistically significant deficiency in the magnitude of the acoustic startle 
response to 90 — 110 dB(A) pulse intensities (Figure 2a). Their deficiency was specific to 
low intensity pulses, as they responded normally to 115 and 120 dB(A) pulses. RMANOVA 
analysis of Upf3b-null and WT genotypes of both sexes revealed a significant interaction of 
genotype x pulse intensity (p <0.002). Post hoc analysis by Fisher PLSD testing confirmed 
reduced acoustic startle magnitude in Upf3b-null vs. control mice for weaker (90 – 100 
dB[A]) pulse intensities (P ≤0.001 for all magnitudes). Female-specific analysis detected a 
similar interaction of genotype x pulse intensity (p <0.05), with reduced acoustic startle 
magnitude in Upf3b-null vs. both WT and heterozygous mice for 90–95 dB(A) pulses (p 
<0.02 – 0.05), and vs. heterozygotes for 100–110 dB(A) pulses (p <0.05) (Figure 2b). 
Deficits in acoustic startle magnitude were not evident in mutants with a 120 dB(A) pulse 
and thus this magnitude pulse was subsequently used to measure PPI (below). Analyses of 
reflex habituation (reduction in startle magnitude from the initial to final trial blocks) 
revealed habituation but no consistent effects of genotype (data not shown).
Prepulse inhibition (PPI) is an operational measure of sensorimotor gating defined as a 
reduction in startle magnitude when the startling pulse is immediately preceded by a weak 
prepulse43,44. Given that human schizophrenia patients exhibit deficient PPI43,45 and 
humans with UPF3B mutations often manifest symptoms of SCZ and other neuropsychiatric 
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disorders associated with impaired PPI25,27,46, we elected to examine PPI of Upf3b-null 
mice. We found that Upf3b-mutant mice had a profound defect in PPI. RMANOVA analysis 
and post hoc Fisher PLSD testing of Upf3b-null and WT genotypes of both sexes revealed a 
significant effect of genotype, when PPI was tested using 100 ms prepulse intervals (gap 
from prepulse onset to pulse onset) and three prepulse intensities (Figure 2c), and when PPI 
was tested using a single 85 dB(A) prepulse intensity and 25 – 500 ms prepulse intervals 
(Figure 2d) (both comparisons: Upf3b-null < WT; p <0.0001). Analyses of only females 
detected a similar effect of genotype across both prepulse intensities and intervals (p 
<0.0006 and <0.0007, respectively), with comparable PPI deficits evident in both Upf3b-null 
and heterozygous female mice (Figures 2e & 2f). Analysis of startle magnitude revealed no 
significant main or interaction effects of genotype or sex (data not shown). This confirms 
that the observed PPI deficits did not reflect potentially confounding group differences in 
startle magnitude. We note that deficient PPI and acoustic startle magnitude in Upf3b-null 
mice could not be explained by primary deficits in auditory sensitivity, as these mice 
exhibited normal auditory sensitivity in measures of auditory evoked potentials (see below).
PPI is regulated by a distributed neural circuitry, with a prominent role of forebrain 
dopamine activity47. To test whether loss of Upf3b acts by perturbing dopamine signaling, 
we elected to test the effect of the potent dopamine D2-receptor antagonist, haloperidol. We 
found that haloperidol did not have a significant effect on either the startle magnitude or PPI 
defects in Upf3b-null mice (Supplementary Figure S5), providing evidence against this 
hypothesis.
To test the possibility that both reduced acoustic startle magnitude and reduced PPI in 
Upf3b-null mice reflects a loss of auditory sensitivity or processing, we measured the 
auditory evoked potential (AEP) response in Upf3b-null and WT mice. Brain stem potentials 
were measured at four decibel levels (65, 68, 70, and 80 dB) and latencies and amplitudes of 
the seven wave forms (P1–P7) were recorded for each. Middle latency potentials were 
recorded in response to two decibel levels (65 & 70 dB) and latencies and amplitudes of the 
four wave forms (Po, Na, Pa, and N2) were recorded for each. The effect of 70 dB is shown 
for illustrative purposes. We observed no significant effects of genotype, sex, or interactions 
involving genotype for any measure of AEP response (Supplementary Figure S6). All mice 
responded in the normal range, indicating that auditory stimuli were being processed. These 
results suggest that Upf3b-null mice have no deficit in auditory sensitivity or processing. 
Thus, the PPI and startle reflex magnitude deficits in Upf3b-null mice are independent of an 
auditory defect.
Upf3b-null neurons have reduced mature dendritic spines
Previous studies have demonstrated that several mouse models with perturbed neural 
function defects have dendritic spine defects43,48,49,50. To examine whether Upf3b-null mice 
harbor dendritic spine defects, we examined dendritic spine density and morphology using 
Golgi staining and bright-field confocal microscopy (Figure 3a). In cortical pyramidal 
neurons, we observed a statistically significant reduction in dendritic spine density in Upf3b-
null mice relative to control mice (Figures 3a & 3b). We also detected a significant decrease 
in the dendritic spine density in dentate granule cells of the hippocampus (Figure 3c). As 
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evidence of specificity, pyramidal neurons in the hippocampal CA1 region did not have 
significantly reduced dendritic spine density (Figure 3d). To examine the underlying defect, 
we quantified the different categories of dendritic spines in cortical pyramidal neurons. We 
found that Upf3b-null mice had significantly fewer mature spines than in control mice, but 
normal numbers of immature spines (Figure 3e). This is consistent with the possibility that 
UPF3B promotes the maturation of dendritic spines in cortical pyramidal neurons.
Upf3b-null neural progenitors exhibit hyper self-renewal and poorly differentiate
In addition to functioning in neural maturation, we considered the possibility that Upf3b has 
roles in neural development. To test this hypothesis, we performed in vitro differentiation 
assays on cortical mouse neural stem cells (mNSCs) isolated from embryonic Upf3b-null 
and control brains. This revealed several lines of evidence that Upf3b-null mNSCs have a 
defect in their capacity to differentiate. First, Upf3b-null mNSCs grown under multipotent 
differentiating conditions for five days had lower expression of several early neuronal 
marker genes (Tuj1 [Tubb3], NeuroD1, and Psd95) compared to wild-type mNSCs (Figure 
4a). As further evidence of their immature status, Upf3b-null mNSC cultures also had 
reduced expression of Ascl1 (Figure 4a), which is considered a master transcriptional 
regulator for neuronal differentiation51. Second, NPC marker genes (Nestin and Sox2) were 
expressed at higher levels in Upf3b-null cells grown under differentiation conditions, as 
compared to control cells (Figure 4b). Third, immunofluorescence/cell count analysis 
demonstrated that Upf3b-null cultures grown under multipotent differentiation conditions 
had a greater percentage of cells expressing the NPC marker, SOX2, and a lower percentage 
of cells expressing the differentiation marker, TUBB3 (Figure 4c and Supplementary Figures 
S7a & S7b). Fourth, pulse-chase EdU-labeling followed by immunofluorescence analysis 
showed that the percentage of cells undergoing self-renewing divisions (i.e., giving rise to 
SOX2-positive progeny52,53) was higher for Upf3b-null cultures than control cultures 
(Figure 4d and Supplementary Figure S7b). This higher rate of self-renewal is consistent 
with a differentiation defect. Lastly, pulse-chase EdU-labeling followed by 
immunofluorescence analysis with the proliferation marker, KI-67, demonstrated that 
Upf3b-null cultures were more proliferative than control cultures (Figure 4e and 
Supplementary Figure S7c). Together, these results indicated that Upf3b normally serves to 
limit mNSC self-renewal and to promote neurogenesis.
To further assess the role of Upf3b in neuronal differentiation and maturation, we cultured 
Upf3b-null and control mNSCs under conditions that preferentially drive the differentiation 
and maturation of neurons (as opposed to glial cells; see Materials and Methods). Over an 
extended culture period, we assayed their ability to undergo electrical firing. A multi-
electrode array system was used to examine spontaneous firing and synchronized 
spontaneous firing. During our 4-week analysis, we observed a dramatic delay in the 
synchronized spontaneous firing in Upf3b-null cells as compared to wild-type cells (Figure 
4f). The firing pattern of Upf3b-null and control cells only become comparable after 4 
weeks in vitro culture (Figure 4f). However, even after 4-weeks culture, the frequency of 
spontaneous electrical activity was significantly less in Upf3b-null cells compared to control 
cells (Figure 4g). We conclude that neural cells differentiated from Upf3b-null nNSCs have 
a profound defect in spontaneous electrical firing.
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Identification Upf3b-regulated transcripts in the frontal cortex
Given that UPF3B is a critical factor in a degradation pathway that has roles in neural 
development and function, we elected to identify transcripts regulated by UPF3B in a neural 
context in vivo. To this end, we performed RNA-seq analysis on frontal cortices from 
Upf3b-null and control mice. Principal components analysis (PCA) demonstrated that the 
transcriptome signatures of Upf3b-null and control frontal cortices from individual mice 
clustered separately (Figure 5a). A total of 141 genes were significantly upregulated in the 
Upf3b-null samples as compared to control samples (q <0.05; >1.41-fold change) (Figure 
5b; Supplementary Table 1). Since NMD is a RNA degradation pathway, these genes 
upregulated by loss of UPF3B are candidates to transcribe NMD direct target RNAs. In 
contrast, only 23 genes were downregulated in Upf3b-null mice cortices as compared to 
control cortices (Figure 5b; Supplementary Table 1). The finding that ~5-fold more RNAs 
were significantly upregulated mRNAs than downregulated is consistent with the possibility 
that most of the upregulated mRNAs are NMD direct targets. Another possibility is that 
Upf3b negatively regulates many transcripts through an indirect mechanism. Gene ontology 
analysis38 of the upregulated genes revealed enrichment for numerous functional categories, 
including several functions related to “Adhesion” (Figure 5c). Some genes in these groups 
overlapped with those in the “Behavior” category and have known roles in neural-specific 
functions, as described in the Discussion. To examine whether any of these putative mouse 
NMD target mRNAs are conserved in humans, it would be optimal to compare with human 
frontal cortex or at least human neural-derived cells, but NMD-regulated transcripts have not 
been identified in such contexts. Thus, we instead compared with human genes shown to be 
regulated by NMD in human embryonic stem cells (upregulated in response to depletion of 
UPF154 and identified 10 genes in common with those upregulated in Upf3b-null mouse 
frontal cortex (AGO4, CDH24, ERCC8, FBN2, HIVEP3, RMST, MOV10, PVT1, TNC, and 
WDR83). Given that different types of cells were compared, we regard this as an 
underestimate of conserved NMD targets.
As described in the Introduction, the most reliable feature that targets RNAs for degradation 
by the NMD pathway is an exon-exon junction >55 nt downstream of the stop codon 
defining the end of the main ORF (“dEJ”). We found that 17% of genes upregulated in 
Upf3b-null frontal cortex (45 of 264) had at least one transcript isoform with a dEJ 
(Supplementary Table 2). In contrast, only 6% of the downregulated genes (2 of 34) encoded 
known RNA isoforms with a dEJ (Supplementary Table 2). The presence of a dEJ was 
statistically enriched for upregulated transcripts as compared to downregulated and 
unchanged transcripts (p<0.0005) (Figure 5d). We also examined two other features—long 
3′ UTRs and upstream (u) ORFs55—both of which are known to inconsistently trigger 
NMD, and found that neither of these features were enriched in transcripts upregulated in 
Upf3b-null frontal cortex (Supplementary Table 2).
DISCUSSION
A growing body of literature supports the notion that NMD factors are critical for both 
developing and mature neurons in a wide range of organisms. For example, in D. 
melanogaster, loss of NMD factors leads to defects in synapse architecture and reduction in 
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neurotransmitter strength56. Similar phenotypic defects are caused by mutations in any of 
several different NMD factor genes (smg1, upf2, or smg6), suggesting that perturbed NMD 
(and not another function) is responsible for these fly neural defects. Likewise, in zebrafish 
embryos, depletion of any of a number of NMD factors (Upf1, Upf2, Smg5, Smg6, or 
Smg7) causes similar brain development abnormalities, including severe patterning 
defects57. In mice, global loss of most NMD factors leads to early embryonic lethality, 
precluding analysis of their role in brain development19,58–61. To specifically examine the 
role of NMD in mouse neurons, the NMD factor gene, Upf2, was conditionally mutated 
using Cre-loxP technology, leading to defects in both neural synaptic maturation and axon 
guidance62,63. Mice haploinsufficient for any of a number of EJC factor genes (Magoh, 
Rbm8a, or Eif4a3) suffer from microcephaly accompanied by premature neural 
differentiation and apoptosis64,65. Deficiencies in EJC factors also appears to cause neural 
disease in humans. For example, deletions in 1q21.1, a small region of human chromosome 
1 that includes the gene encoding the EJC core component, RBM8A, has been found to be 
associated with increased incidence of ID, epilepsy, ASD, and SCZ66. Indeed, copy number 
alterations in several EJC and NMD factor genes (RBM8A, EIF4A3, UPF3A, SMG6, and 
RNPS1) are significantly enriched in patients with neurodevelopmental disorders67.
In this paper, we focus on UPF3B, the only NMD gene that has been definitively shown to 
have a role in cognition in humans. In particular, mutations in UPF3B have been shown—
through pedigree analysis—to cause mild-to-severe ID20,23–29,31,68,69. Many patients with 
UPF3B mutation also suffer from neurodevelopmental disorders, including SCZ, ADHD, 
and ASD, providing evidence that UPF3B, and by implication, NMD, have roles in 
developmental processes required for normal behavior. To understand the underlying basis 
for these defects, we generated a mouse model with a null mutation in the Upf3b gene. 
These NMD-deficient mice exhibit specific impairments in fear-conditioned memory and 
sensorimotor gating (Figures 1 & 2) that we postulate stem from the neurogenesis and 
neuronal maturation defects that we defined in cultured Upf3b-null mNSCs (Figure 4 and 
Supplementary Figure S7). Another factor potentially contributing to the behavioral defects 
of Upf3b-null mice is reduced dendritic spine density that we showed occurs in specific 
neuronal populations (Figure 3). To define the RNAs misregulated as a result of NMD 
deficiency, we performed transcriptome profiling on Upf3b-null and control frontal cortices. 
Among the misregulated RNAs were many high-confidence direct NMD target mRNAs 
encoding proteins known to be critical for neural processes.
Behavioral deficits in Upf3b-null mice
Our behavioral analysis revealed that Upf3b-null mice were normal in spatial memory tasks 
(Supplementary Figure S4), but exhibited both contextual and cued conditional fear-learning 
defects (Figures 1a & 1b). By analogy, neuroligin-3 (Nlgn3)-null mice, a model of ASD, 
also exhibit both of these fear-based defects but are normal in spatial memory70. NLGN3 is 
a cell-surface protein expressed on neurons involved in CNS synapse formation and 
remodeling71. We suggest NMD may control the same events through its ability to degrade 
mRNAs encoding synapse formation and remodeling proteins. The amygdala, hippocampus, 
and the prefrontal cortex are all critical for fear memory recognition and downstream 
processes72–74, including storing fear memories72. It will be intriguing in the future to 
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delineate which specific brain regions and neural circuits require UPF3B for fear-
conditioned learning.
Upf3b-null mice also have a striking deficit in PPI, a measure of sensorimotor gating 
(Figures 2c–f). PPI deficits have been reported in a variety of human neuropsychiatric 
disorders, including SCZ, as well as mouse models displaying ID and ASD, such as Fmr1-, 
Fmr1/Fxr2-, Nrxn1a-, and Pten-KO mice75–78. Interestingly, several mouse mutants 
(including Fmr1-KO mice) also harbor deficits in the magnitude of the acoustic startle 
reflex75, just as we found for Upf3b-null mice (Figure 2a & 2b). Future studies will be 
directed towards determining the underlying mechanism responsible for the PPI deficits in 
Upf3b-null mice. Reduced PPI can result from perturbations of normal activity within 
distributed neural circuitry connecting several different brain regions, including the 
prefrontal- and limbic-cortical, striatal, pallidal, thalamic and pontine structures47. Our 
finding that the PPI deficit in Upf3b-null mice is not significantly “rescued” by haloperidol 
(Figure S5) suggests that it does not reflect subcortical (striatal or n. accumbens) dopamine 
hyperfunction47. PPI deficits in schizophrenia patients are also not rescued by treatment with 
haloperidol79.
Both PPI and fear-conditioned learning are regulated by the prefrontal cortex43 and thus the 
abnormally low dendritic spine density we observed in Upf3b-null prefrontal cortex 
pyramidal neurons (Figure 3) may contribute to one or both of these behavioral defects. 
Consistent with this, reduced cortical dendritic spine density is an often-reported neural 
deficits in SCZ and ID patients, as well as mouse models for these conditions80–83. It will be 
intriguing in the future to determine whether a common defect underlies the learning/
memory and PPI deficits in Upf3b-null mice.
We found that Upf3b-null mice have a selective reduction in mature, not immature, dendritic 
spines (Figure 3e), suggesting that NMD promotes dendritic spine maturation. NMD may do 
this through regulation of mRNAs encoding proteins involved in this process. Alternatively, 
this regulation may occur locally—such as in the dendrites themselves—as UPF3B has been 
previously identified in dendrites and dendritic spines of mouse primary E17.5 hippocampal 
neurons, using tagged recombinant UPF3B protein26. Other NMD factors—UPF1, UPF2, 
and SMG1—have been shown to be enriched in axons of distal commissural axons in the 
developing mouse spinal cord62. NMD is a regulated process in developing neurons28,29, 
and thus we suggest that this pathway may selectively degrade transcripts in dendrites in a 
developmentally regulated manner in order to influence their maturation. While we do not 
know the physiological consequences of the dendritic spine defect in Upf3b-null mice, it is 
tempting to speculate that it has a role in one or more of the behavioral defects in these mice. 
This follows from the roles of dendritic spines in synaptic connectivity and the fact that mice 
with many different types of behavioral defects also have deficient dendritic spines. Relevant 
to our study, PPI-deficient mouse models have been shown to exhibit abnormal cortical and 
hippocampal dendritic spine morphology43,48 and mice harboring fear conditioning and 
sleep defects exhibit remodeled dendritic spines in the cortex49,50.
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The role of Upf3b in neurogenesis
To investigate whether Upf3b-null mice have neurogenesis defects that could be responsible 
for their behavioral defects, we generated and analyzed mNSC lines from Upf3b-null and 
control embryos. We found that Upf3b-null mNSCs exhibit increased self-renewal and 
decreased neurogenesis relative to control mNSCs (Figure 4 and Supplementary Figure S7), 
suggesting that UPF3B serves to promote NSC differentiation. A similar conclusion was 
reached by Jolly et al., who found that depletion of UPF3B (by RNAi) from later stage 
neurons (E18.5 NSCs and isolated hippocampal neurons) inhibited their differentiation or 
maturation31. We also found that the development of electrical activity is impaired in Upf3b-
null NSC-derived neurons (Figures 4f & 4g, Supplementary Figure S7d). This raises the 
possibility that UPF3B promotes not only early neurogenesis but also neuronal maturation. 
However, it is also possible that the electrical firing defect results from inefficient 
differentiation at an earlier stage of neural development (Figure 4 and Supplementary Figure 
S7). While a differentiation defect may be a contributing factor, several lines of evidence 
suggest that a maturation defect also has a role in the impaired electrical activity of Upf3b-
null neural cells. First, we used culture condition known to efficiently generate neurons for 
our electrophysiology experiments30. Second, Upf3b-null NSCs began differentiating very 
soon after being put under such culture conditions (~35% began differentiating, based on 
two markers, after only 3 days of culture [Fig 4c]), yet these Upf3b-null do not generate 
significant action potentials until much later (after 28 days in culture, with little or no 
activity after 7, 14, or 21 days in culture [Fig 4g]). Third, we previously reported that mouse 
NSCs depleted of UPF3B (using RNAi) undergo less than one additional division (on 
average) before differentiation, making it unlikely that UPF3B depletion simply lead to an 
accumulation of undifferentiated proliferating cells31. Finally, our finding that Upf3b-null 
mice have dendritic spine defects (Figure 3) is supportive of a role in UPF3B in neural 
maturation in vivo. Regardless of the precise roles of UPF3B in neural differentiation and 
maturation, our analysis clearly indicates that UPF3B is critical for the efficient and timely 
generation of functional neurons in vitro, providing an explanation for the behavioral defects 
caused by loss of functional UPF3B in vivo.
Accumulating data suggest that UPF3B is highly regulated during neuronal development. 
For instance, both UPF3B mRNA and UPF3B protein were shown to be downregulated in a 
rat neural stem line upon differentiation84. In contrast, Upf3b mRNA expression increases 
during cortical neuron maturation, with highest level in synaptically active neuronal 
networks31. Consistent with this upregulated pattern of expression, Upf3b is expressed at 
higher level in adult brains than embryonic and postnatal mice brains in vivo31. Interestingly, 
Upf3b expression in mature neurons is also regulated by synaptic activity; depolarization of 
hippocampal neuron depresses Upf3b expression31. Spatially, both Upf3b mRNA and 
UPF3B protein are broadly expressed in most structures and cell types in the brain, but they 
are differentially expressed in some specific brain regions. While the function of UPF3B in 
mature neurons is not known, it is present in not only in the cell body, but also neurites31,84, 
consistent with evidence that NMD regulates synaptic transmission and targets mRNAs that 
function at the synapse in mammalian cells85,86. In flies, even hemizygous mutations in 
NMD factor genes have been shown to be sufficient to disturb synapse structure and 
function56. NMD also functions in axon guidance, as shown in mouse commissural 
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neurons87. In the future, it will be important to define the specific roles of UPF3B at the 
synapse, in axon guidance, and other functions in mature neurons.
Our findings that UPF3B promotes neural differentiation is in apparent contradiction with 
our laboratory’s previous finding that another NMD factor, UPF1, inhibits neural 
differentiation28. In that study, we found that depletion of UPF1 was sufficient to trigger 
multi-potent P19 cells to differentiate down the neural cell lineage28. Conversely, preventing 
the UPF1 downregulatory response that is normally triggered by neural differentiation cues 
largely prevented neural differentiation of both P19 and mNSCs, as judged by both neural 
and stem cell markers. How does one reconcile these results in light of the findings reported 
here? One possibility is that NMD has opposite effects on different stages of neural 
development. Thus, while NMD promotes the proliferative and stem-like state of 
multipotent cells [represented by P19 cells88], it may instead promote the differentiation of 
already committed neural stem cells (represented by mNSCs). In support of this, we 
previously found that while depletion of UPF1 in mNSCs decreased the level of 
pluripotency markers (such as Oct4 and Nanog), it increased neural stem markers, such as 
Sox2, Nestin, and Dcx28. This is analogous to what we observed in response to loss of 
UPF3B (Fig. 4).
A non-mutually exclusive possibility is that UPF1 and UPF3B have different functions. 
Because UPF3B appears to drive a specific branch of the NMD pathway16,89, it may 
promote the decay of a specific subset of transcripts that promotes neural differentiation. In 
contrast, because UPF1 is an essential NMD factor that appears to be required for all NMD 
branches16,18, it may degrade a larger set of transcripts that, on balance, promote the 
opposite response – maintenance of the stem-like state. While the UPF3B-dependent branch 
of NMD may exhibit unique effects in neural cells, it is worthy of note that in another 
system—human embryonic stem cells—UPF1 and UPF3B manipulation (whether depletion 
or forced expression) have very similar effects on primary germ layer differentiation90.
The neural defects caused by loss of Upf3b are strikingly different from the phenotypic 
consequences of loss-of-function mutations in other NMD genes. Mutational inactivation of 
Upf1, Upf2, Upf3a, Smg1, or Smg6 leads to early embryonically lethality, at the pre- or 
peri-implantation stage19,58–61. One explanation for why loss of Upf3b does not cause 
embryonic lethality is because it encodes a NMD branch-specific factor16,21. By promoting 
the decay of only a subset of NMD substrates, UPF3B might only drive specific 
developmental events in vivo, such as those involving brain development, but not those 
involving early embryonic development. Another possibility is that UPF3B is a NMD 
amplifier and thus developing cells that either require high levels of NMD and/or are 
particularly sensitive to alterations in NMD magnitude will be specifically perturbed by loss 
of UPF3B.
Upf3b-regulated transcripts in the cerebral cortex
To begin to understand the molecular roles of UPF3B in the nervous system, we performed 
transcriptome profiling of Upf3b-null vs. control frontal cortex. A remarkably specific 
cohort of mRNAs were upregulated and thus candidates to be degraded by the NMD 
pathway. Table 1 lists Upf3b-regulated genes that have been shown to have functions in the 
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nervous system and neural disease. Intriguingly, 20 of the 21 coding genes have at least one 
NMD-inducing features, suggesting many of them encode direct NMD target RNAs. Several 
of these encode adhesion proteins involved in neural processes, including DSCAM, 
DSCAML1, PCDH15, ITGA8, SDK2, and CDH24. DSCAM and its paralog, DSCAML1, 
are transmembrane proteins critical for cortical neural networks; they perform a variety of 
functions, including dendritic self-avoidance, dendritic arborization, and promotion of axon 
growth and synaptic connections. The integrin, ITGA8, and the cadherin protein, CDH24, 
are both involved in synaptic adhesion through promoting neurite and/or axonal outgrowth. 
CDH24 mRNA appears to be a conserved target of NMD, as it was also identified as being 
degraded by NMD in human ES cells90. PCDH15 is another member of the cadherin 
superfamily; it is broadly expressed in the embryonic brain and is critical for forming 
filaments in sensory hair cells in the developing inner ear. In addition to targeting mRNAs 
encoding adhesion proteins directing synaptic connections and activity, UPF3B may also 
promote the decay of mRNAs encoding the ligands involved in these events. As a case in 
point, the UPF3B-regulated transcript, Sema4g, encodes a member of a large family of 
secreted proteins, some of which serve as axon guidance ligands.
Interestingly, some UPF3B-targeted transcripts encode proteins involved in retinal neural 
cell connectivity. For example, DSCAM and DSCAML1 function in dendritic self-avoidance 
of specific interneuron types, leading to lamina-specific synaptic connections in the 
mammalian retina. We also identified Sdk2 and Col18a1 as UPF3B-regulated mRNAs. The 
former encodes a member of the immunoglobulin superfamily that promotes lamina-specific 
synaptic connections in the retina and is specifically required for the formation of neuronal 
circuits that detect motion. The latter encodes a type XVIII collagen deposited in the 
extracellular matrix that is thought to have roles in retina formation. These putative NMD 
targets involved in eye development are of interest, as increasing evidence suggests roles for 
NMD in the eye. For example, in D. melanogaster, genetic mosaic analysis revealed that cell 
clones lacking functional Upf1 or Upf2 fail to contribute to the eye in adult flies91. If wild-
type cells are eliminated from these mosaic animals, the remaining NMD-deficient cells 
proliferate and differentiate to form eyes but they are smaller than normal and disorganized. 
This suggests that NMD acts by promoting the proliferation and patterning of neural cells 
that form the insect eye. In humans, the loss of the entire NMD pathway is likely to be 
embryonic lethal (based on mouse knockout studies19,58–61) and thus a direct comparison 
with these fly studies cannot be made, but it is known that many patients with mutations in 
the NMD branch-specific factor gene, UPF3B, suffer from strabismus and/or cataracts26.
Other UPF3B-regulated transcripts of potential relevance to the nervous system are Fbn2, 
Tnc, Kcnh4, Ptch1, Rmst, and Brca2. Fbn2 and Tnc both encode extracellular matrix 
proteins and thus represent putative NMD targets in the same general class as those 
encoding adhesion proteins, as described above. Fbn2 encodes FIBRILIN-2, a component of 
connective tissue microfibrils that is critical for TGF-β bioavailability92, and thus it may 
have a role in the known ability of NMD to regulate TGF-β signaling events critical for 
neurogenesis and other developmental pathways28,90. Tnc encodes tenascin C, a 
glycoprotein that is restricted in its expression in the CNS to neurogeneic areas. Both Tnc 
and Fbn2 mRNA appears to be a conserved NMD targets, based on them being upregulated 
not only in mouse Upf3b-null cortex (herein), but NMD-deficient human cells16,90. Kcnh4 
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encodes a potassium voltage-gated channel expressed in both the neocortex and the striatum 
and thus is likely to be involved in cellular excitability in neurons in these regions of the 
CNS. Ptch1, Rmst, and Brca2 are all critical for neurogenesis. Ptch1 encodes a receptor for 
the secreted signaling molecule, sonic hedgehog, which has important roles in various 
aspects of neural development, including motor neuron generation and neurogenesis in the 
adult hippocampus. Rmst is a non-coding RNA that cooperates with SOX2 to influence 
neural stem cell fate and neuronal differentiation93. While non-coding RNAs are seemingly 
paradoxical NMD targets given that NMD requires translation94, it has recently come to 
light that even though non-coding RNAs do not encode large proteins, many of them are 
translated, based on polysome and genome-wide ribosome profiling analysis95–99. Brca2 
encodes a multifunctional DNA-binding protein critical for repair of DNA strand breaks. 
While best known as a tumor suppressor gene in epithelial cells, BRCA2 is also critical for 
neurons, as it repairs DNA-strand breaks that occur naturally during neurogenesis100. 
Indeed, many neurally expressed genes and their promoters undergo DNA breakage at 
relatively high frequency101,102 and thus the possibility that NMD influences repair of these 
breaks through regulated decay of BRCA2 mRNA is of considerable interest.
The human orthologs corresponding to several mouse UPF3B-regulated genes are 
implicated in human neural diseases. For example, many UPF3B KO-upregulated candidate 
NMD target mRNAs that we identified in Upf3b-null cerebral cortex correspond to recently 
defined SCZ disease risk genes (DSCAM, HIVEP3, MOV10, NIN, SPEN, AKR1C2, 
ARL5C, CD59, and VWA5B1)103. Among these disease risk genes is DSCAM, which 
encodes Down syndrome cell adhesion molecule, a transmembrane protein that is highly 
expressed in the developing fetal CNS. It is encoded by chromosome 21 in humans and 
causes Down syndrome symptoms when overexpressed. Another UPF3B-regulated gene is 
Pcdh15, which when mutated in humans causes Usher Syndrome type 1F, a developmental 
disorder that presents with visual, hearing, and sleep defects, and, in some cases, 
neuropsychiatric symptoms, including ASD and biopolar disorder. Finally, mutations in the 
UPF3B-regulated gene, Col18a1, cause one form of Knobloch syndrome, which presents 
with severe eyesight problems, cataracts, and retinal degeneration.
In summary, our study introduces a mouse model that has the potential to elucidate the in 
vivo roles of a highly conserved and selective RNA decay pathway in neuronal development 
and behavior. Intriguingly, these Upf3b-null mice exhibit strikingly similar phenotypes as 
mouse models for other human neurodevelopmental disorders. This raises the possibility that 
the steady-state levels of specific mRNAs encoding proteins important for pathways critical 
for normal neural development are regulated by NMD. Given that Upf3b-null mice exhibit 
behavioral defects that mimic, in some respects, those of humans with UPF3B mutations, 
these mice may also serve as a model system to understand the neuropathology in these 
patients. Not only may this reveal the underlying basis for their learning and memory 
deficits, but the PPI deficits in Upf3b-null mice may prove useful in understanding the basis 
for impaired PPI in a wide variety of human brain disorders, including SCZ. Our 
identification of dysregulated transcripts in the cerebral cortex of these NMD-deficient mice 
provides an important resource for future investigations into the molecular basis for 
behavioral defects, including those impinging on normal learning and sensorimotor gating. 
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We suggest that the study of NMD provides a novel portal into key genes critical for normal 
neural development and behavior.
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Figure 1. 
Upf3b-null mice have cued/contextual fear learning defects and sleep alterations. (a & b) 
Measurement of freezing times during habituation periods and after cue introduction and 
contextual environment introduction in males and females combined (a) and females alone 
(b). Analysis of 12 Upf3b−/Y (null) and 13 Upf3b+/Y (control) males; 14 Upf3b−/−, 14 Upf3b
+/−
 and 12 Upf3b+/+ females. (c & d) Measurement of time in light and dark environments in 
wakefulness, slow wave, non-REM sleep in males and females combined (c), and females 
alone (d). Analysis of 9 Upf3b−/Y (null) and 9 Upf3b+/Y (control) males; 6 Upf3b−/−, 6 
Upf3b+/− and 5 Upf3b+/+ females. For all panels, statistically significant differences, as 
measured by a Fisher’s PLSD test, are indicated (*p<0.05; **p<0.01; ***p<0.005). Error 
bars indicate SEM.
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Figure 2. 
Upf3b-null display startle and PPI deficits. (a & b) Measurement of the startle magnitude 
across different startle pulse intensities in males and females combined (a), and females 
alone (b). (c & d) Prepulse inhibition measured at different prepulse intensities (78 – 86 
dB(A) with a 70 dB(A) background) (c) or at different prepulse intervals (25 – 500 ms) (d) 
in males and females combined. (e & f) The same analysis as in panels c and d except that 
females alone were analyzed. Analysis of 12 Upf3b−/Y (null) and 13 Upf3b+/Y (control) 
males; 14 Upf3b−/−, 14 Upf3b+/− and 12 Upf3b+/+ females. Error bars indicate SEM. The 
text discusses statistically significant effects, as measured by RMANOVA analysis and the 
Fisher PLSD test.
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Figure 3. 
Dendritic spine analysis in Upf3b-null mice. (a) Image of prefrontal cortex stained with the 
Golgi-Cox protocol to reveal neuronal morphology in wild type and Upf3b-null mice. (b–d) 
Quantification of dendritic spine density in different neuronal populations in Upf3b-null and 
control brains: pyramidal neurons in the frontal cortex (b), granule cells from the dentate 
gyrus (c), and pyramidal neurons in the CA1 region of the hippocampus (d). (e) 
Quantification of different categories of spine based on maturation stage between Upf3b-null 
and control pyramidal neurons in the frontal cortex. * denotes statistically significant 
different values in panels a–e, as judged using the Students T-Test (p<0.05; n=3 per 
genotype). Error bar denote SEM.
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Figure 4. 
Upf3b-null NSCs exhibit differentiation defects. (a & b) qPCR analysis of neuronal 
differentiation markers (a) and NPC markers (b) expressed in Upf3b-null and control (wild 
type) mNSC lines cultured for 5 days under differentiation conditions. (c) Frequency of cells 
expressing the NPC marker, SOX2, and the neural differentiation markers, TUBB3 and 
GFAP, 5 days after differentiation in vitro. (d & e) Frequency of self-renewing mNSC cells, 
as measured with NPC marker, SOX2 (d), or the proliferation marker, KI67 (e) and pulse-
chase EdU labeling (d & e). (f) Measurement of electrical activity in Upf3b-null and control 
mNSCs differentiated for the days indicated in vitro. Each indicated interval is a 20 s 
window of a 300 s recording. (g) Quantification of synchronized firing per 300 s, from 
experiments performed as in panel f (three independent mNSC lines [each derived from 
separate embryos] per genotype were analyzed). * denotes statistically significant different 
values, as judged using the Student’s t test (p<0.05). Three independent mNSC lines [each 
derived from separate embryos] per genotype were analyzed. Data points represent mean of 
biological replicates (n=3 per genotype). Error bars denote standard deviation.
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Figure 5. 
Identification Upf3b-regulated transcripts in the frontal cortex using RNA sequencing. (a) 
Principal component analysis (PCA) of Upf3b-null and control frontal cortices (n=5 and 6, 
respectively), with each point representing a cortex sample from a single mouse. Data was 
plotted along the first and second principal components. (b) Differentially expressed genes 
in Upf3b-null frontal cortex samples compared to wild type controls identified 141 genes 
upregulated upon loss of Upf3b (q<0.05, >1.41-fold change). (c) Gene ontology analysis of 
RNAs upregulated upon loss of Upf3b in the frontal cortex indicated enrichment for several 
functional categories. (d) The presence of a dEJ was statistically enriched in transcripts 
upregulated in Upf3b-null cortex, as compared to downregulated and unchanged transcripts 
(Chi-square test; p<0.0005). This RNAseq data has been deposited in the GEO DataSets site 
(GSE99112).
Huang et al. Page 28
Mol Psychiatry. Author manuscript; available in PMC 2018 September 27.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Huang et al. Page 29
Table 1
NMD-Inducing Features in Neural-Associated UPF3B-Regulated Genes
Gene dEJI Long 3′UTRII uORFIII
Akr1c14 No Yes Yes
Arl5c No No No
Brca2 No No Yes
Cd59a No Yes Yes
Cdh24 No No Yes
Col18a1 No Yes No
Dscam No Yes Yes
Dscaml1 Yes Yes Yes
Fbn2 No Yes No
Hivep3 No Yes Yes
Itga8 Yes Yes No
Kcnh4 Yes No Yes
Mov10 No No Yes
Nin No No Yes
Pcdh15 Yes Yes Yes
Ptch1 Yes Yes Yes
Sdk2 No Yes No
Sem4g Yes Yes Yes
Spen No Yes Yes
Tnc No No Yes
Vwa5b1 Yes Yes Yes
Rmst Non-coding RNA
Genes upregulated in Upf3b-null frontal cortex that express at least 1 transcript isoform with the following NMD-inducing features:
I
exon-exon junction >50 nt downstream of the main ORF
II3′UTR ≥0.9 kb
III
at least one uORF with features as described (Shum et al. Nucleic Acids Res 43:9314 [2015])
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